UBS Group’s Cavium, Inc. CAVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-1,240,773
| Closed | -$107M | – | 8624 |
|
|
2018
Q2 | $107M | Sell |
1,240,773
-561,001
| -31% | -$44.9M | 0.05% | 383 |
|
|
2018
Q1 | $143M | Buy |
1,801,774
+942,399
| +110% | +$82.3M | 0.06% | 292 |
|
|
2017
Q4 | $72M | Buy |
859,375
+816,335
| +1,897% | +$63.2M | 0.03% | 521 |
|
|
2017
Q3 | $2.84M | Buy |
43,040
+4,556
| +12% | +$288K | ﹤0.01% | 2771 |
|
|
2017
Q2 | $2.39M | Sell |
38,484
-18,363
| -32% | -$1.28M | ﹤0.01% | 2848 |
|
|
2017
Q1 | $4.07M | Buy |
56,847
+23,302
| +69% | +$1.56M | ﹤0.01% | 2266 |
|
|
2016
Q4 | $2.1M | Sell |
33,545
-65,968
| -66% | -$3.81M | ﹤0.01% | 2875 |
|
|
2016
Q3 | $5.79M | Buy |
99,513
+58,946
| +145% | +$2.95M | ﹤0.01% | 1890 |
|
|
2016
Q2 | $1.56M | Buy |
40,567
+5,651
| +16% | +$279K | ﹤0.01% | 2984 |
|
|
2016
Q1 | $2.13M | Sell |
34,916
-9,188
| -21% | -$530K | ﹤0.01% | 2608 |
|
|
2015
Q4 | $2.9M | Buy |
44,104
+3,341
| +8% | +$225K | ﹤0.01% | 2463 |
|
|
2015
Q3 | $2.5M | Sell |
40,763
-5,065
| -11% | -$338K | ﹤0.01% | 2536 |
|
|
2015
Q2 | $3.15M | Buy |
45,828
+6,960
| +18% | +$488K | ﹤0.01% | 2535 |
|
|
2015
Q1 | $2.75M | Buy |
38,868
+3,455
| +10% | +$224K | ﹤0.01% | 2625 |
|
|
2014
Q4 | $2.19M | Buy |
+35,413
| New | +$1.87M | ﹤0.01% | 2822 |
|
UBS Group's CAVM Position: Q3 2018 in Review
UBS Group sold out of Cavium, Inc. (CAVM) in Q3 2018, closing a stake of 1,240,773 shares — an estimated $107M sold.
UBS Group first reported a position in CAVM in Q4 2014 and held it in 15 quarters. The position peaked at $143M in Q1 2018. 0 funds tracked by Wall St. Rank hold CAVM as of Q3 2018.
- UBS Group reported no remaining Cavium, Inc. position as of Q3 2018 after selling out during the quarter.
- UBS Group sold 1,240,773 Cavium, Inc. shares in Q3 2018, an estimated $107M.
- UBS Group first reported a position in Cavium, Inc. in Q4 2014 and held it in 15 quarters.
- UBS Group's Cavium, Inc. position peaked at $143M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cavium, Inc. as of Q3 2018.
Based on UBS Group's 13F filing for Q3 2018, filed 14 Nov 2018.